The Nevyas Drape Support is the simple and inexpensive way to establish a zone of comfort for your patients during ophthalmic surgery which requires draping over the nose and mouth. Packaged in sets
The Multi-Cap system provides patients with the ability to quickly change from distance viewing to reading. The telescope has a magnification of 1.75x for distance viewing. The double lens caps are
The longer working distances achieved by the use of Galilean optics make this the perfect magnifier to enable the patient to read and write.
The Redi-glaze spectacle magnifier is an aspheric lens, glazed into a standard Keeler LVA frame.
Medicine Products:(Date:12/3/2008)... NY) A new study led by researchers at Albert Ein...s clarified how two major variants of HIV differ i... The finding, published in Journal of Neuroscien...prevent HIV-associated dementia, an incurable and ...DS. Even with anti-retroviral drug therapies, up t...
(Date:12/3/2008)...swire-FirstCall/ -- Memory Pharmaceuticals,Corp. ...r 3, 2008, the Company,received notification from...nel") that the Panel has determined to delist the ...et. However, the Company was also notified today ...l (the "Review Council") has,called for review th...
(Date:12/3/2008)...-- Breast-Specific Gamma Imaging (BSGI) has,equiv...st MRI in patients with,inconclusive findings aft...,breast cancer, according to findings presented to...iety of North America (RSNA). BSGI is a molecular ...ol to mammography that can identify,lesions indep...
(Date:12/3/2008)...rst not helped by maintenance treatment, study sho...) -- Maintenance therapy using low-dose peginterfe...patitis C who haven,t responded to an initial roun...udy also showed a surprising health decline in pat...ears. , "This course of treatment had been adop...
Breaking Medicine News(10 mins):Health News:Study sheds light on causes of HIV dementia 2Health News:Study sheds light on causes of HIV dementia 3Health News:Memory Pharmaceuticals Receives NASDAQ Decisions 2Health News:Memory Pharmaceuticals Receives NASDAQ Decisions 3Health News:Molecular Breast Imaging Outperforms MRI for Patients With Inconclusive Results in the Diagnosis of Cancer 2Health News:Hepatitis C Therapy Useless for Some 2...dered Friday that schoolgirls in Texas must be vac...t causes cervical cancer, making Texas the first s...to get Merck & Co.'s new vaccine against strains o...HPV, that are responsible for most cases of cervic...
...Pinewood elementary in Prince George, Canada are d...rips were served to them as part of the school’s//... food poisoning was registered only after school a...ber of parents phoned in to tell their child was t...
...ing grumblings about being tired or exhausted, peo...e they lead to a worsened health state or even dea...igating fatigue. Dr. Karin Olson, a U of A profes...that there are differences between tiredness, fati...
...on men in the United States over age 20 are affect... by researchers from the Johns Hopkins Bloomberg S... dysfunction was strongly linked with age, cardiov...physical activity. The findings also indicate th...
Other Medicine News:Health News:Take Fatigue Seriously - Says Researcher 2Health News:Take Fatigue Seriously - Says Researcher 3Health News:More Than 18 Million US Men Affected by ED 2(Date:12/2/2008).... 2 Biopure Corporation,...aval Medical Research Center,(NMRC) has submitted...ed,investigational new drug (IND) application to ...therapeutic Hemopure(R) [hemoglobin glutamer - 250...ment of trauma patients. The study is,entitled "O...
(Date:12/2/2008)... Horizon Therapeutics, Inc., a,pri...nced that two pivotal,Phase 3 trials evaluating i...,met all primary endpoints. HZT-501, a novel, pr...ng ibuprofen and famotidine, demonstrated a,stati... non-steroidal,anti-inflammatory drug (NSAID)-ind...
(Date:12/1/2008)...CAGO, Dec. 2 A study ha...a new technique for imaging the breast, is not aff...al status, two factors that limit the effectivenes...cer. Results will be presented today at the annual...ica (RSNA). , , "The ability of PEM to det...
(Date:12/1/2008)...Newswire/ -- S*BIO Pte Ltd today announced the ini... potent and orally-active JAK2 inhibitor, in leadi...chronic idiopathic myelofibrosis (CIMF). , ,...d tolerability of SB1518 in patients with CIMF and...e 1 part of the study will assess the safety profi...
Breaking Medicine Technology:U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3FDA Sunscreen Labeling Decision Delayed Another Month Leading U S Physician to Say Enough Is Enough 7225 1FDA Sunscreen Labeling Decision Delayed Another Month Leading U S Physician to Say Enough Is Enough 7225 2Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 1Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 2Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 3Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 4Sumitomo Corporation Appoints New Chairman to U S Animal Healthcare Company Summit VetPharm LLC 7223 5Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 1Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 2Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 3Caliper Life Sciences to Participate in Deutsche Banks Healthcare Technology Industry Day 2011 1... announced today,that Lipitor (atorvastatin calciu...ary heart disease events and major coronary events...nary heart disease,but who had experienced a recen...e results are from a new analysis of the landmark,...sterol Levels,(SPARCL) trial, and were presented a...
...s Demonstrates,Public Health Threat; Colonization ...Facility Units, SAN JOSE, Calif., June 25, 2007 /P...ssionals in Infection Control and Epidemiology,(AP...de study of,1,237 U.S. healthcare facilities, exam...hylococcus aureus (MRSA), a virulent,multi-drug re...
Other Medicine Technology:Lipitor Reduced the Risk of Coronary Events by Half and Stroke by,Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who,Experienced a Recent Stroke 2Lipitor Reduced the Risk of Coronary Events by Half and Stroke by,Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who,Experienced a Recent Stroke 3Largest National U.S. Healthcare Facility MRSA Study Reveals,Infection Rates Eight Times Greater Than Previous Estimates 2Largest National U.S. Healthcare Facility MRSA Study Reveals,Infection Rates Eight Times Greater Than Previous Estimates 3